Chronic pain in Parkinson disease
DOI:
https://doi.org/10.12775/JEHS.2020.10.05.033Keywords
Parkinson disease, chronic pain, pathogenesis, physiologyAbstract
The study was aimed to assess the modern trends explaining pathogenesis of chronic pain amongst patients with PD. The information search in the open sources was conducted using databases OVID, PubMed and EMBASE, the depth of search was in time frame after 2010. Content analysis was provided for the most pertinent literature reviews and clinical trials. There were selected 12 sources amongst 89 primary found references.
There were discussed the main domains of pathogenesis of chronic pain in Parkinson disease. The approaches to pain management in PD patients primarily depend on the underlying cause. The presence of chronic pain syndrome should be considered as a reason for assessing the adequacy of antiparkinsonian therapy
References
Cabreira V, Massano J. Doença de Parkinson: Revisão Clínica e Atualização. Acta Med Port. 2019;32(10):661-670. doi:10.20344/amp.11978
Ascherio A, Schwarzschild MA. The epidemiology of Parkinson's disease: risk factors and prevention. Lancet Neurol. 2016;15(12):1257-1272. doi:10.1016/S1474-4422(16)30230-7
Capriotti T, Terzakis K. Parkinson Disease. Home Healthc Now. 2016;34(6):300-307. doi:10.1097/NHH.0000000000000398
Lotankar S, Prabhavalkar KS, Bhatt LK. Biomarkers for Parkinson's Disease: Recent Advancement. Neurosci Bull. 2017;33(5):585-597. doi:10.1007/s12264-017-0183-5
Pavlishina, NN Pain in Parkinson's disease [Text] / NN Pavlishina, IV Khubetova, AN Stoyanov // Neurology and neurosurgery. Eastern Europe. - 2017. - Volume 7, N 3. - S. 440-449 (in Russian)
6. Khubetova I.V. Characteristics of pain in Parkinson's disease / I.V. Khubetova // Actual problems of transport medicine 2019 - № 1 (55) - P. 87-92 (in Russian)
Antonini A, Tinazzi M, Abbruzzese G, et al. Pain in Parkinson's disease: facts and uncertainties. Eur J Neurol. 2018;25(7):917-e69. doi:10.1111/ene.13624
Blanchet PJ, Brefel-Courbon C. Chronic pain and pain processing in Parkinson's disease. Prog Neuropsychopharmacol Biol Psychiatry. 2018;87(Pt B):200-206. doi:10.1016/j.pnpbp.2017.10.010
Jost WH, Buhmann C. The challenge of pain in the pharmacological management of Parkinson's disease. Expert Opin Pharmacother. 2019;20(15):1847-1854. doi:10.1080/14656566.2019.1639672
Buhmann C, Wrobel N, Grashorn W, et al. Pain in Parkinson disease: a cross-sectional survey of its prevalence, specifics, and therapy. J Neurol. 2017;264(4):758-769. doi:10.1007/s00415-017-8426-y
Fil A, Cano-de-la-Cuerda R, Muñoz-Hellín E, Vela L, Ramiro-González M, Fernández-de-Las-Peñas C. Pain in Parkinson disease: a review of the literature. Parkinsonism Relat Disord. 2013;19(3):285. doi:10.1016/j.parkreldis.2012.11.009
12. Makhnev SO Chronic pain syndromes in Parkinson's disease / SO Makhnev, OS Levin; [in the book: Parkinson's disease and movement disorder. Guide for Physicians]; ed. S. N. Illarioshkin, O. S. Levin. - M., 2011 .-- S. 83-87. (in Russian)
Downloads
Published
How to Cite
Issue
Section
License
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 503
Number of citations: 0
